CalciMedica is trading 5.6% up today at $0.78 as the stock stabilizes following sharp swings tied to its recent FDA-related rally and subsequent sell-off.
- The move appears driven primarily by ongoing trading dynamics and a broader risk-on market tone.
- There are no fresh company-specific news or new regulatory developments reported to account for the current price action.